Focus Rheums| ACR Convergence 2024 Previews

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Rheumatologist John P. Atkinson, MD, Continues Research into Rare Diseases

  |  Issue: February 2015  |  

More Excitement Than Ever

After 45 years of conducting research, Dr. Atkinson’s appetite for discovering the unknown hasn’t shrunk a bit. Neither has his love of sports: He recently stopped playing basketball only because he couldn’t find an “over 70” league.

With no plans to retire anytime soon, he will continue doing targeted, deep sequencing to find the cause of more diseases.

ADVERTISEMENT
SCROLL TO CONTINUE

“Thanks to modern genetics, we are now more easily able to figure out human diseases,” says Dr. Atkinson. “This is the major reason I’m still active. It’s more exciting than ever to be a basic and translational scientist than at any time in my career.”

Carol Patton is a freelance writer based in Las Vegas, Nev., and writes the Rheum after 5 column for The Rheumatologist.

ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles
    Dr. Yokoyama, MD, with Jennifer Laurent

    Interdisciplinary Collaboration at Wash U Advances Understanding of Immunology, Rheumatology

    In June 2014, 10 members of a church group returned to St. Louis from Haiti, where they had contracted chikungunya virus (CHIKV), a mosquito-transmitted alphavirus previously unknown in the Western hemisphere that produces inflammatory arthritis symptoms. Because CHIKV-related arthritis mimics seronegative RA, a group of clinicians, immunologists, virologists and geneticists at the Washington University in…

    Motortion Films / shutterstock.com

    A Look Back at Pirquet & Schick’s Influential Serum Sickness Study

    In 1905, two pediatricians in Vienna, Austria, published Serum Sickness, a detailed 120-page monograph that was the first to carefully characterize the syndrome.1 The work would go on to become a classic, ultimately helping illuminate many important questions in immunology. Antitoxin Serum Treatments In the late 19th century, researchers were working to develop lifesaving antitoxins…

    The 2019 ACR Award Winners & Distinguished Fellows

    ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

    2015 ACR/ARHP Annual Meeting: Cellular Triggers in Inflammatory Disease

    SAN FRANCISCO—What factors help determine whether or not inflammation resolves, leading to healing, or becomes chronic, leading to disease and tissue destruction? A number of important cells, including toll-like receptors, mast cells, anti-citrullinated protein antibodies, complement and interferon, all play their own role in this process. By understanding how they act in innate and adaptive…